Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: APR 246 PLUS AZACITIDINE (AZA) IN TP53 MUTATED (M) MDS AND AML. LONG TERM FOLLOW UP OF PHASE 2 STUDY BY THE GFM. (September 2021)

Record Type:
Journal Article
Title:
Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: APR 246 PLUS AZACITIDINE (AZA) IN TP53 MUTATED (M) MDS AND AML. LONG TERM FOLLOW UP OF PHASE 2 STUDY BY THE GFM. (September 2021)
Main Title:
Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III
Authors:
Cluzeau, T.
Sebert, M.
Rahmé, R.
Cuzzubbo, S.
Walter-Petrich, A.
Peterlin, P.
Recher, C.
Stamatoullas, A.
Willems, L.
Raffoux, E.
Berthon, C.
Sallman, D.
Ades, L.
Fenaux, P.
Abstract:
Is Part Of:
Leukemia research. Volume 108(2021)Supplement
Journal:
Leukemia research
Issue:
Volume 108(2021)Supplement
Issue Display:
Volume 108, Issue 2021 (2021)
Year:
2021
Volume:
108
Issue:
2021
Issue Sort Value:
2021-0108-2021-0000
Page Start:
Page End:
Publication Date:
2021-09
Subjects:
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:
http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.leukres.2021.106680.11 ↗
Languages:
English
ISSNs:
0145-2126
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
19703.xml